Berbamine, a natural bisbenzyl-isoquinoline alkaloid, attenuates hepatic steatosis by activating the SIRT1/LKB1/AMPK signaling axis in high-fat diet (HFD)-induced non-alcoholic fatty liver disease (NAFLD) rats. Here, SIRT1 is linked to metabolic dysfunction-associated steatotic liver disease.